Guided Therapeutics, Inc. (GTHP)
OTCMKTS
· Delayed Price · Currency is USD
0.1250
+0.0350 (38.89%)
May 16, 2025, 3:08 PM EDT
Guided Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 0 | 0.01 | 0.1 | 0.01 | 0.08 | 0.1 | Upgrade
|
| Revenue Growth (YoY) | -98.78% | -92.86% | 653.85% | -83.95% | -20.59% | 183.33% | Upgrade
|
| Cost of Revenue | 0 | 0.01 | 0.06 | 0.08 | 0.06 | -0.04 | Upgrade
|
| Gross Profit | -0 | 0 | 0.04 | -0.07 | 0.02 | 0.14 | Upgrade
|
| Selling, General & Admin | 1.62 | 1.58 | 2.53 | 3.19 | 2.31 | 1.05 | Upgrade
|
| Research & Development | 0.55 | 0.53 | 0.23 | 0.08 | 0.07 | 0.14 | Upgrade
|
| Operating Expenses | 2.16 | 2.11 | 2.75 | 3.27 | 2.38 | 1.2 | Upgrade
|
| Operating Income | -2.16 | -2.11 | -2.72 | -3.33 | -2.36 | -1.05 | Upgrade
|
| Interest Expense | -0.46 | -0.38 | -0.28 | -0.58 | -1.15 | -1.06 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0.01 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.15 | - | 0.04 | 0.04 | 0.86 | 2.13 | Upgrade
|
| EBT Excluding Unusual Items | -2.48 | -2.49 | -2.95 | -3.87 | -2.65 | 0.02 | Upgrade
|
| Other Unusual Items | 0.04 | 0.07 | -0.54 | -0.47 | 0.58 | -0.3 | Upgrade
|
| Pretax Income | -2.44 | -2.42 | -3.49 | -4.34 | -2.07 | -0.28 | Upgrade
|
| Net Income | -2.44 | -2.42 | -3.49 | -4.34 | -2.07 | -0.28 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.17 | 0.17 | 0.27 | 0.63 | 0.36 | 0.12 | Upgrade
|
| Net Income to Common | -2.61 | -2.59 | -3.76 | -4.97 | -2.43 | -0.4 | Upgrade
|
| Shares Outstanding (Basic) | 61 | 57 | 51 | 33 | 13 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 61 | 57 | 51 | 33 | 13 | 11 | Upgrade
|
| Shares Change (YoY) | 15.68% | 12.14% | 57.30% | 142.99% | 24.24% | 226.07% | Upgrade
|
| EPS (Basic) | -0.04 | -0.05 | -0.07 | -0.15 | -0.18 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.05 | -0.07 | -0.15 | -0.18 | -0.04 | Upgrade
|
| Free Cash Flow | -1.35 | -1.12 | -1.75 | -1.51 | -1.61 | -1.88 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.03 | -0.05 | -0.12 | -0.17 | Upgrade
|
| Gross Margin | -200.00% | 28.57% | 36.73% | - | 24.69% | 140.20% | Upgrade
|
| Operating Margin | -216300.00% | -30114.29% | -2773.29% | -25638.46% | -2916.05% | -1031.37% | Upgrade
|
| Profit Margin | -261300.00% | -37014.29% | -3835.71% | -38246.15% | -3001.24% | -393.14% | Upgrade
|
| Free Cash Flow Margin | -135000.00% | -15985.71% | -1781.63% | -11615.39% | -1982.72% | -1839.22% | Upgrade
|
| EBITDA | -2.15 | -2.1 | -2.71 | -3.33 | -2.36 | -1.03 | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0 | 0 | 0.02 | Upgrade
|
| EBIT | -2.16 | -2.11 | -2.72 | -3.33 | -2.36 | -1.05 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.